Biocracked
Approach 3, the human outcome, in palette B, warm.

Low three-quarter rear angle, shot with a 50mm lens at shallow depth of field. A middle-aged person's forearm and hand grip a loaded barbell mid-deadlift, the tendons and the muscle of the forearm clearly defined, with chalk dust hanging in the air. Their face is out of frame. The setting is a plain home garage gym with a rubber floor and a rack softly blurred in the background. Low golden-hour sunlight comes through an open roll-up door and rakes across the skin and the knurled steel, casting long warm shadows. Amber, copper and honey tones dominate, with matte black plates for contrast. A tiny electric green silicone wristband or a small green pen injector resting on a nearby shelf adds a subtle accent. The mood is determined, quiet and hopeful.
Metabolism

Bab Tirzepatide: Angkat Beban Nglindhungi 1,1 kg Massa Otot

Rex Meridian · · 4 min read

Tirzepatide bisa ngilangi luwih saka 22 kg sajrone 40 minggu. Siji uji coba acak anyar nuduhaké yèn, tanpa angkat beban, kira‑kira 4,7 kg saka penurunan kuwi yaiku jaringan otot, lan kekuwatan malah mudhun. Angkat beban telung kali seminggu ngowahi gambaran iki.

Uji coba sing diterbitaké ing Nature Medicine (online sadurunge cetak, 2026) iku salah siji tes manungsa paling cetha nganti saiki kanggo ndelok apa latihan resistensi isa njaga jaringan otot nalika ngurangi bobot nganggo obat incretin.

Cara Penelitiane: 120 Wong, 40 Minggu, Siji Obat

Para peneliti saka University of Western Australia lan institusi kolaborasi ngrekrut 120 wong diwasa sing kegemukan utawa obesitas. Kabeh diwènèhi tirzepatide. Sawisé iku, peserta dipérang sacara acak dadi loro klompok:

  • Tirzepatide waé (T): aktivitas kaya biyasane
  • Tirzepatide + latihan resistensi (T+REx): latihan resistensi telung kali seminggu

Intervensi iki dilakokaké 40 minggu. Tirzepatide dilaporké aman, lan mayoritas peserta isa nambah dosis nganti 15 mg saben minggu, dosis paling dhuwur. Ketaatan marang program latihan resistensi yaiku 91 %.

Iki uji coba acak terkontrol ing manungsa, dudu uji coba ing kéwan utawa sel. Uji coba iki kadaptar (ACTRN12623001236684).

Angka‑angka Utama

Bobot lan penurunan lemak: podho ing loro klompok

Angkat beban ora ngalangi efek utama obat.

  • Penurunan bobot: T = -22,61 kg vs T+REx = -22,28 kg (P = 0,694)
  • Penurunan total lemak: T = -17,19 kg vs T+REx = -17,98 kg (P = 0,700)

Bedane lemak antar klompok yaiku -0,77 kg (95 % CI -2,14 nganti 0,60 kg), mula ora ana prabédan sing signifikan.

Massa otot: ngendi angkat beban nggawe bedane

  • Total massa jaringan lunak otot: T = -4,67 kg vs T+REx = -3,57 kg (P < 0,001)
  • Bedane antar klompok: 1,09 kg (95 % CI 0,43 nganti 1,75 kg)
  • Massa jaringan lunak otot ekstremitas (tangan lan sikil): T = -3,55 kg vs T+REx = -2,92 kg (P < 0,001)

Para peserta sing ngangkat beban ora nambah massa otot, nanging kelangan luwih sethithik. Miturut perhitungan saka angka sing dilaporaké, iki kira‑kira seprapat luwih sithik kelangan otot tinimbang klompok sing mung obat. Abstrak artikel nyebut efek iki minangka "attenuation", lan tembung kuwi pancen pas.

Kekuwatan: mudhun ing grup obat waé, mundhak karo angkat beban

Hasil kekuwatan iki sing paling mencolok.

Tes Tirzepatide waé Tirzepatide + REx
Bench press -4,09 kg +4,68 kg
Lat pulldown -4,42 kg +8,58 kg
Knee extension -4,42 kg +5,88 kg

Kabeh bedane dibandhingaké karo tirzepatide waé signifikan (P < 0,001). Tanpa latihan, kekuwatan awak ndhuwur lan ngisor mudhun. Kanthi latihan, kekuwatan munggah ing saben tes.

Protokol Latihan: Apa sing Ditérakaké Abstrak

Abstrak mung nyebut sawetara rincian:

  • Frekuensi: telung kali seminggu
  • Durasi: 40 minggu
  • Ketaatan: 91 %
  • Kelompok otot sing dites: bench press (dorong awak ndhuwur), lat pulldown (tarik awak ndhuwur) lan knee extension (gerakan sikil)

Abstrak ora nyebut set, repetisi, beban, utawa progresi. Rincian kuwi mesthine ana ing artikel lengkap, dadi priksa dhisik sadurunge niru program tartamtu. Olahraga sing dites nuduhaké templat sing masuk akal: siji dorong, siji tarik, lan siji gerakan sikil.

Pelajaran Praktis

1. Rencanakake telung sesi saben minggu. Iki jadwal sing ngasilaké asil, lan peserta ngetutaké 91 % wektu.

2. Ngurusi kabeh awak. Peningkatan kekuwatan katon ing dorong, tarik, lan latihan sikil, mula rencana full‑body iku cara sing wajar.

3. Ngarepake nglindhungi otot, ora mesti nambah. Loro klompok kelangan massa otot. Angkat beban ngurangi kelangan kira‑kira 1,1 kg.

4. Aja kuwatir yèn angkat beban ngurangi penurunan lemak. Penurunan bobot lan lemak statistiké podho antar klompok.

5. Protein. Abstrak ora nyebut asupan protein, mula uji coba iki ora bisa maringi target protein. Pedoman nutrisi olahraga lan sarcopenia umum negesaké asupan protein sing cukup bareng latihan resistensi. Diskusikna jumlah spesifik karo dhokter utawa ahli gizi.

6. Dosis. Mayoritas peserta tekan 15 mg mingguan, nanging dosis diputusaké dokter, ora dening uji coba iki. Angkat beban mung tambahan, ora dadi alesan kanggo ngowahi dosis.

Sapa Sing Cocok

Temuan iki paling relevan kanggo wong diwasa sing kegemukan utawa obesitas lan nggunakake tirzepatide (Mounjaro/Zepbound). Kekhawatiran babagan kelangan otot luwih penting kanggo wong tuwa, sing cadangan ototé luwih sithik lan luwih rawan lemes lan tiba. Abstrak ora nyebut umur peserta utawa analisis subkelompok kanggo wong tuwa, mula ora jelas apa asil iki uga berlaku kanggo wong tuwa. Wong tuwa lan sapa wae sing duwe masalah sendi, jantung, utawa kondisi medis liyané kudu konsultasi karo dhokter lan idealé entuk pelatih sadurunge miwiti program angkat beban.

Cathetan Penting

  • "Jaringan lunak otot" ora mung otot murni. Isiné banyu lan jaringan organ. Peningkatan kekuwatan nuduhaké manfaat fungsional, nanging ukuran iki ora ngukur otot langsung.
  • Masih ana kelangan otot. Pengangkat kelangan 3,57 kg jaringan lunak otot, dadi latihan resistensi mung ngurangi kelangan, ora ngilangaké kabeh.
  • Durasi. Data mung nutupi 40 minggu. Apa sing kedadeyan sawisé mandheg obat utawa latihan ora dibahas ing abstrak.
  • Pengungkapan. Sawetara penulis nglaporaké honorarium utawa peran penasihat karo perusahaan farmasi, kalebu Eli Lilly sing nggawe tirzepatide. Kabeh honorarium dibayar menyang University of Western Australia. Siji penulis uga dadi pemegang saham lan penasihat klinis ProGenis Pharmaceuticals.

Kesimpulan

Tirzepatide ngasilaké penurunan bobot lan lemak sing gedhé, nanging uga nyedhot massa otot lan kekuwatan. Nambahake latihan angkat beban telung kali seminggu selama 40 minggu njaga penurunan lemak tetep, ngurangi kelangan massa otot kira‑kira 1,1 kg, lan mbalikke penurunan kekuwatan. Kanggo wong sing nggunakake obat kelas GLP‑1, uji coba iki menehi alesan kanggo nggabungaké latihan resistensi ing rencana perawatan. Artikel iki mung kanggo informasi lan dudu saran medis.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

RM

Written by

Rex Meridian

Rex Meridian writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: conceptual metaphor. Palette: D, bold color field.

A single steel dumbbell sits in the center of a saturated tomato-red seamless backdrop. A thick, taut rope of frayed tan fibers wraps around its handle, and a few strands are visibly thinning and unraveling at one end while the rest stay dense and intact, standing for muscle being preserved while weight drops. Shot at a low three-quarter angle with a shallow depth of field, so the knurled grip texture is crisp and the background melts into smooth red. Hard, directional studio light from the upper left casts a sharp, short shadow on the glossy red surface. One thin electric green cable tie is cinched around the rope. The mood is punchy, tense and editorial, with no people and no text.
peptides

Apa Sing Cocok Digabungaké karo Tirzepatide Supaya Otot Tetep? Tikus Punya Jawaban

BY NOVA CHEN ·

Tirzepatide bisa ngilangi bobot kanthi cepet, nanging kepiye karo ototmu? Siji studi tikus anyar nyoba obat iki dhewe lan digabungaké karo pola mangan wektu winates lan latihan beban. Kombinasi iki mempercepat ilangé bobot lan lemak, latihan beban njaga otot lan kekuatan, lan TRF bareng tirzepatide ningkataké toleransi glukosa. Manfaat kanggo ati padha ing kabeh perlakuan. Riset iki mung ing tikus wadon kegemukan, mula anggep iki sinyal menjanjikan, dudu protokol kanggo manungsa.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Apa Ozempic lan Mounjaro Nggawa Depresi? Temuan saka 20 Studi

BY DR. SYNAPSE ·

Apa Ozempic lan Mounjaro bisa nambah risiko depresi utawa pikiran bunuh diri? Saka tinjauan sistematis 20 studi lan penilaian regulator EMA lan FDA, bukti paling kuat ora nuduhake risiko kasebut. Meta-analisis gedhe 2025 ora nemokake kenaikan suicidality, depresi, utawa kecemasan karo semaglutide utawa tirzepatide. Sinyal sing muncul luwih akeh amarga desain studi sing ora bisa misahake efek obat saka stres obesitas, risiko psikiatrik dhasar, lan bias pelaporan. Amarga uji coba asring ngilangi pasien psikiatrik, pengawasan tetep penting kanggo kelompok risiko dhuwur lan kanggo nglacak efek jangka panjang sing arang kelakon.

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutide Ora Ngerusak Sel Otot Manungsa, Dadi Kok Otot Kethil?

BY DR. SYNAPSE ·

Apa semaglutide bener‑bener nyerang otot? Panaliten ing *GeroScience* ngaplikasikake semaglutide langsung marang sel otot primer manungsa sing wis tuwa lan kegemukan, lan sel‑sel mau ora kethil. Ora ana gen atrofik sing diaktifake, ora ana sinyal darurat sing ngganggu, malah GIP nambah kandel myotube sawise wolu dina. Semaglutide mung nyuda produksi ATP liwat glikolisis kanthi sithik, lan reseptor GLP‑1 mung sithik ditemokake. Asilé nuduhaké yèn mundhut massa otot luwih disebabake defisit kalori lan beban sing suda, dudu amarga semaglutide langsung ngrusak otot.

Approach: Macro science. Palette: B, warm.

Extreme macro photograph of a clear glass vial of blood plasma held in a gloved hand, shot at a slight low angle so the camera looks up through the tube. The plasma is cloudy and creamy at the top, where large fat-rich particles gather, and it clears to translucent golden amber toward the bottom, showing the drop in triglyceride particles. Tiny suspended droplets catch the light as bright specks. Warm honey-colored backlight from a low window-like source glows through the liquid and casts copper highlights across the glass. The background is a soft blur of warm brown and amber, with a faint electric green reflection on the rim of the vial cap. The mood is calm, precise and cautious, with a shallow depth of field and a real clinical texture on the glass. No text or labels.
metabolism

Retatrutide Ngurangi Partikel Trigliserida Ageng nganti 84 %—Nanging Waca Dhisik

BY DR. SYNAPSE ·

Retatrutide paling misuwur amarga kemampuan ngedhunake bobot awak, nanging analisis post‑hoc saka loro uji fase 2 nemokaké efek signifikan ing getih. Partikel lipoprotein sing kebak trigliserida (TRL) gedhé mudhun nganti 84,4 % ing pasien diabetes tipe 2, lan ApoB mudhun kira‑kira 21‑24 %. Ing uji tanpa diabetes, hsCRP mudhun 54,8 % lan IL‑6 mudhun 29,6 %, nanging perubahan iki ora signifikan ing uji diabetes. Iki dudu suplemen, nanging obat resep sing durung disetujoni, lan biomarker iki mung sinyal, ora bukti penurunan risiko serangan jantung.

This page is available in